China NMPA Product Recall - Cortisone acetate eye drops

The Anhui Provincial Food and Drug Administration, operating under the National Medical Products Administration (NMPA), issued a regulatory order for Wuhu Sanyi Pharmaceutical Co., Ltd. to recall multiple batches of its Cortisone Acetate Eye Drops. This action followed recent drug supervision and inspection activities, which revealed that the eye drops did not meet established standards, specifically regarding dosage. Such non-compliance poses a significant risk to patient safety and the therapeutic efficacy of the medication. Consequently, Wuhu Sanyi Pharmaceutical Co., Ltd. was mandated to complete the recall of all affected product batches by November 25, 2010. Concurrently, the regulatory authority has initiated a comprehensive investigation into the company's production processes. This inquiry aims to identify the root causes of the quality control deficiencies and ensure that the company implements necessary corrective measures to prevent future recurrence. This incident underscores the NMPA's commitment to rigorous oversight of pharmaceutical manufacturing and product quality to protect public health.